Annual report pursuant to Section 13 and 15(d)

Equity Transactions (Warrants) (Narrative) (Details)

v3.21.1
Equity Transactions (Warrants) (Narrative) (Details) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
May 22, 2018
Apr. 20, 2018
Oct. 31, 2018
May 31, 2018
Apr. 30, 2018
Nov. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Shares reserved in conncetion with convertible notes with detachable warrants             80,000,000  
Convertible Note Dated April 20, 2018 [Member]                
Unamortized debt discount   $ 15,000            
Convertible Note Dated May 22, 2018 [Member]                
Unamortized debt discount $ 25,000              
Convertible Promissory Note [Member]                
No of stock or warrants granted           2,000,000    
Award terms           In October and November 2020, in combination with a 5-year convertible promissory note, the Company granted warrants to purchase a total of 2,000,000 shares of restricted common stock with an exercise prices of $0.25 and will expire on various dates between October 5, 2025 and November 24, 2025. The warrants are fully vested and exercisable upon grant.    
Fair value of stock or warrants at grant date           $ 0    
Exercise price of warrants             $ 0.25  
Proceeds allocated to warrants and recorded as paid in capital and debt discount             $ 0  
Warrants [Member]                
No of stock or warrants granted             2,800,000 100,000
Exercise price of warrants             $ 0.08  
Share price             $ 0.08  
Description of shares reserved with court approves settlement             The Company has reserved 80,000,000 shares of common stock in connection with convertible notes with detachable warrants, 100,000,000 shares of common stock in connection with shares underlying an equity line of credit and 3,500,000 shares of common stock underlying warrants issued in connection with the court approved settlement agreement for a total of 183,500,000 reserved shares of common stock.  
Warrants [Member] | Advisory Services Agreement [Member]                
No of stock or warrants granted     100,000          
Award terms     In October 2019, pursuant to advisory services agreement, the Company granted warrants to purchase a total of 100,000 shares of restricted common stock with an exercise price of $0.50 and expiration date of October 30, 2020. The warrants are fully vested and exercisable upon grant. Total fair value of the options at grant date amounted to $1,000 computed using the Black-Scholes Option Pricing Model and was fully recognized on the date of grant.          
Fair value of stock or warrants at grant date     $ 1,000          
Warrants expiration date     Oct. 30, 2020          
Exercise price of warrants     $ 0.50          
Warrants [Member] | Convertible Note Dated April 20, 2018 [Member]                
No of stock or warrants granted         500,000      
Award terms   The noteholder was also granted detachable 3-year warrants to purchase 200,000 shares of the company’s restricted common stock at an exercise price of $0.375 per share, 200,000 shares of the company’s restricted common stock at an exercise price of $0.50 per share, and 100,000 shares of the company’s restricted common stock at an exercise price of $0.625 per share.     In April 2018, in combination with a 12-month convertible promissory note, as amended, the Company granted warrants to purchase a total of 500,000 shares of restricted common stock with an exercise price of $0.25 and will expire April 20, 2021. The warrants are fully vested and exercisable upon grant.      
Warrants expiration date         Apr. 20, 2021      
Exercise price of warrants         $ 0.25      
Proceeds allocated to warrants and recorded as paid in capital and debt discount         $ 61,000      
Unamortized debt discount             $ 0 $ 18,000
Debt settlement cost             9,000  
Warrants [Member] | Convertible Note Dated May 22, 2018 [Member]                
No of stock or warrants granted       200,000        
Award terms The noteholder was also granted detachable 5-year warrants to purchase 500,000 shares of the company’s restricted common stock at an exercise price of $2.00 per share.     In May 2018, in combination with an 8-month convertible promissory note, as amended, the Company granted warrants to purchase a total of 1,200,000 shares of restricted common stock with an exercise prices of $0.25 and will expire May 22, 2023. The warrants are fully vested and exercisable upon grant.        
Warrants expiration date       May 22, 2023        
Exercise price of warrants       $ 0.25        
Proceeds allocated to warrants and recorded as paid in capital and debt discount       $ 32,000        
Unamortized debt discount             0 $ 3,000
Debt settlement cost             $ 87,000